The application of immunological mechanisms to fight cancer may be complicated when cellular products are to be employed. The development of chemical-based, synthetic methods may provide an attractive alternative. A poly (lactic- glycolic acid) PLGA nano bead platform is therefore being developed by Figdor, aiming to generate new synthetic vaccines and to develop synthetic Dendritic Cells to directly activate T cells.